Literature DB >> 34511845

Preface: Cardiorenal Considerations for Type 2 Diabetes-Time to Exit the Dark Ages.

Ralph A DeFronzo, Guest Editor.   

Abstract

Entities:  

Year:  2021        PMID： 34511845      PMCID： PMC8387613          DOI： 10.2337/ds20-0081

Source DB:  PubMed          Journal:  Diabetes Spectr        ISSN： 1040-9165


× No keyword cloud information.
  6 in total

Review 1.  Pioglitazone: The forgotten, cost-effective cardioprotective drug for type 2 diabetes.

Authors:  Ralph A DeFronzo; Silvio Inzucchi; Muhammad Abdul-Ghani; Steven E Nissen
Journal:  Diab Vasc Dis Res       Date:  2019-02-01       Impact factor: 3.291

2.  Effect of chronic hyperglycemia on in vivo insulin secretion in partially pancreatectomized rats.

Authors:  L Rossetti; G I Shulman; W Zawalich; R A DeFronzo
Journal:  J Clin Invest       Date:  1987-10       Impact factor: 14.808

3.  The GLP-1 derivative NN2211 restores beta-cell sensitivity to glucose in type 2 diabetic patients after a single dose.

Authors:  Annette M Chang; Grethe Jakobsen; Jeppe Sturis; Marla J Smith; Cathie J Bloem; Bob An; Andrzej Galecki; Jeffrey B Halter
Journal:  Diabetes       Date:  2003-07       Impact factor: 9.461

4.  Endogenous Glucose Production and Hormonal Changes in Response to Canagliflozin and Liraglutide Combination Therapy.

Authors:  Robert Martinez; Hussein Al-Jobori; Ali M Ali; John Adams; Muhammad Abdul-Ghani; Curtis Triplitt; Ralph A DeFronzo; Eugenio Cersosimo
Journal:  Diabetes       Date:  2018-03-30       Impact factor: 9.461

5.  Correction of hyperglycemia with phlorizin normalizes tissue sensitivity to insulin in diabetic rats.

Authors:  L Rossetti; D Smith; G I Shulman; D Papachristou; R A DeFronzo
Journal:  J Clin Invest       Date:  1987-05       Impact factor: 14.808

6.  Effects of exenatide on measures of β-cell function after 3 years in metformin-treated patients with type 2 diabetes.

Authors:  Mathijs C Bunck; Anja Cornér; Bjorn Eliasson; Robert J Heine; Rimma M Shaginian; Marja-Riitta Taskinen; Ulf Smith; Hannele Yki-Järvinen; Michaela Diamant
Journal:  Diabetes Care       Date:  2011-09       Impact factor: 19.112
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.